Pharmacological evidence that the inhibitory effects of prostaglandin E2 are mediated by the EP2 and EP4 receptors in human neutrophils
Journal of Leukocyte Biology · 2024
DOI: 10.1093/jleuko/qiae029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2024. Verfasst von Jean-Philippe C Lavoie und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Département de médecine, Faculté de médecine, Université …. Hauptthemen laut MEDLINE: Receptors, Prostaglandin E, EP4 Subtype, Receptors, Prostaglandin E, EP2 Subtype, Neutrophils, Dinoprostone. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Natural Sciences and Engineering Research Council of Canada, CIHR, Fonds de recherche du Québec-Santé.
Abstract (Originalsprache)
Prostaglandin E2 (PGE2) is a recognized inhibitor of granulocyte functions. However, most of the data supporting this was obtained when available pharmacological tools mainly targeted the EP2 receptor. Herein, we revisited the inhibitory effect of PGE2 on reactive oxygen species production, leukotriene biosynthesis, and migration in human neutrophils. Our data confirm the inhibitory effect of PGE2 on these functions and unravel that the effect of PGE2 on human neutrophils is obtained by the combined action of EP2 and EP4 agonism. Accordingly, we also demonstrate that the inhibitory effect of PGE2 is fully prevented only by the combination of EP2 and EP4 receptor antagonists, underscoring the importance of targeting both receptors in the effect of PGE2. Conversely, we also show that the inhibition of ROS production by human eosinophils only involves the EP4 receptor, despite the fact that they also express the EP2 receptor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec, Département de médecine, Faculté de médecine, Université Laval, 2725 Chemin Sainte-Foy, Québec City, QC G1V 4G5, Canada.
- Canada Excellence Research Chair on the Microbiome-Endocannabinoidome Axis in Metabolic Health, Université Laval, 2325 Rue de l'Université, Québec City, QC G1V 0A6, Canada.
- Département de microbiologie et immunologie, Faculté de Médecine de l'Université Laval, Centre de Recherche du CHU de Québec, Université Laval, 2325 Rue de l'Université, Québec City, QC G1V 0A6, Canada.
- Axe maladies infectieuses et immunitaires, Centre de Recherche du CHU de Québec, Université Laval, 2725 Boulevard Laurier, Québec City, QC G1V 4G2, Canada.
- Endocannabinoid Research Group, Institute of Biomolecular Chemistry, Consiglio Nazionale Delle Ricerche, 80078 Pozzuoli, Italy.
- Institut sur la nutrition et les aliments fonctionnels, Centre NUTRISS, École de Nutrition, Faculté des Sciences de l'agriculture et de l'alimentation, Université Laval, 2440 Bd Hochelaga Suite 1710, Québec City, QC G1V…
ORCID-Profile: Nicolas Flamand
Förderung
- Natural Sciences and Engineering Research Council of Canada
- CIHR
- Fonds de recherche du Québec-Santé
- Frederick Banting and Charles Best Canada Graduate Scholarship from the Canadian Institutes of Health Research
- Canadian Institutes of Health Research
- Fonds de recherche du Québec—Santé
Zitieren
APA
Lavoie, J. C., Simard, M., Kalkan, H., Rakotoarivelo, V., Huot, S., Di Marzo, V., Côté, A., Pouliot, M., & Flamand, N. (2024). Pharmacological evidence that the inhibitory effects of prostaglandin E2 are mediated by the EP2 and EP4 receptors in human neutrophils. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiae029
Vancouver
Lavoie JC, Simard M, Kalkan H, Rakotoarivelo V, Huot S, Di Marzo V, et al. Pharmacological evidence that the inhibitory effects of prostaglandin E2 are mediated by the EP2 and EP4 receptors in human neutrophils. Journal of Leukocyte Biology. 2024. doi:10.1093/jleuko/qiae029
BibTeX
@article{Lavoie2024,
author = {Lavoie, Jean-Philippe C and Simard, Mélissa and Kalkan, Hilal and Rakotoarivelo, Volatiana and Huot, Sandrine and Di Marzo, Vincenzo and Côté, Andréanne and Pouliot, Marc and Flamand, Nicolas},
title = {Pharmacological evidence that the inhibitory effects of prostaglandin E2 are mediated by the EP2 and EP4 receptors in human neutrophils},
journal = {Journal of Leukocyte Biology},
year = {2024},
doi = {10.1093/jleuko/qiae029}
}
EUVIMED